CSI Launches OrbusNeich’s Jade OTW Noncompliant Peripheral Balloon Catheters in the United States

June 1, 2021—Cardiovascular Systems, Inc. (CSI) announced that the full line of OrbusNeich Jade percutaneous transluminal angioplasty (PTA) over-the-wire (OTW) balloon catheters is now available in the United States. CSI is the exclusive United States distributor of OrbusNeich balloon products.

Jade is an OTW balloon catheter for PTA in the peripheral vasculature, including obstructed native arteries and synthetic arteriovenous dialysis fistulae, as well as for postdilatation of balloon expandable and self-expanding stents.

According to CSI, Jade is a noncompliant balloon designed for high pressure tolerance and balloon dilatation with even pressure distribution for the treatment of complex lesions. These balloons are compatible with standard 0.014-, 0.018-, and 0.035-inch guidewires, and with catheter working lengths ranging from 135 cm to 200 cm, and balloon working lengths from 20 mm to 240 mm.

Kousta Issa Foteh, MD, from Vital Heart and Vein in Humble, Texas, and Siddhartha Rao, MD, from Vascular Solutions of North Carolina in Cary, North Carolina, were two of the first physicians in the United States to adopt the full line of Jade devices in their practices.

“I was eager to add the full line of Jade PTA balloons to my practice,” commented Dr. Foteh in the CSI press release. “The predictable, uniform inflation of these noncompliant balloons allows for accuracy in balloon sizing and reduces the potential for vessel recoil.”

Dr. Rao stated, “The deliverability of the Jade balloons, whether it be on the 0.014-, 0.018-, or 0.035-inch platform, is exceptional. These balloons have consistently allowed me to cross and treat challenging lesions successfully in situations where I would have previously failed with other balloons.”